Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akio Hyodo is active.

Publication


Featured researches published by Akio Hyodo.


European Journal of Medicinal Chemistry | 1998

Synthesis and antibacterial activity of 7-hydrazinoquinolones

Rajeshwar Singh; Rakhshandeh Fathi-Afshar; George Thomas; Maya P. Singh; Fusahiro Higashitani; Akio Hyodo; Norio Unemi; Ronald G. Micetich

A series of new C-7 substituted hydrazino quinolones and naphthyridines were prepared and tested for antibacterial activity. The hydrazine bridge at the C-7 position did not favor the antibacterial activity, whereas the nature of other substituents at N-1, C-5 and C-8 did noticeably influence the antibacterial activity. The 7-(1-aminomorpholino) derivatives exhibited superior antibacterial activity against Gram-positive and inferior activity against Gram-negative bacteria than the 7-(1-aminopiperazinyl) derivatives. Substitution of the quinolone at position-1 with cyclopropyl was the most beneficial for antibacterial activity among the series of compounds prepared.


Chemistry of Heterocyclic Compounds | 1998

Studies on monobactams I. Synthesis and β-lactamase inhibitory activity of 4-substituted 3-[(N-methyl-1,2,3-triazol-4-yl)-methylene]-2-azetidinone-1-sulfonates

Oludotun A. Phillips; David P. Czajkowski; Kevin Atchison; Ronald G. Micetich; Samarendra N. Maiti; Chieko Kunugita; Akio Hyodo

Two monobactam derivatives, potassium (3Z)-[(N-methyl-1,2,3-triazol-4-yl)methylene]-4-phenylthio-2-azetidinone-1-sulfonate and potassium (3E)-[(N-methyl-1,2,3-triazol-4-yl)methylene]-4-(1,2,3-triazol-1-yl)-2-azetidinone-1-sulfonate, were synthesized and tested for β-lactamase inhibitory activity.


Chemotherapy | 1997

Superior Effect of Tazobactam/ Piperacillin Compared to Piperacillin on β-Lactamase-Producing Pseudomonas aeruginosa

Kouichi Nishida; Fusahiro Higashitani; Akio Hyodo

To evaluate the synergistic antimicrobial effects of tazobactam (TAZ), a beta-lactamase inhibitor, and piperacillin (PIPC) on Pseudomonas aeruginosa, we compared the antimicrobial effects of TAZ/PIPC with those of PIPC alone on bacteria inducibly or constitutively producing beta-lactamase. TAZ/PIPC had more potent antimicrobial effects compared with PIPC on clinical isolates producing beta-lactamase. In the treatment of mouse systemic infection, the therapeutic effect of PIPC was markedly decreased by beta-lactamase, but that of TAZ/PIPC was only slightly decreased. In the treatment of local infections in mice, the therapeutic effects of PIPC were decreased due to the induction of beta-lactamase and the emergence of bacterial strains constitutively producing beta-lactamase, while those of TAZ/ PIPC were not affected.


European Journal of Medicinal Chemistry | 1995

Synthesis and in vitro antimicrobial activity of 3-heteroarylsulphonylmethyl cephems: a new class of cephalosporins

Maya P. Singh; Rajeshwar Singh; Sn Maiti; P. Spevak; N. Ishida; Akio Hyodo; Ronald G. Micetich

Summary A series of 3-heteroarylsulphonylmethyl and 3-heteroarylsulphenylmethyl cephems were prepared and tested for antimicrobial activities. In contrast to the adverse effect of oxidized ring sulphur of penams and cephems on antimicrobial activities, the oxidized side-chain sulphur of 3-mercaptoheteroaryl cephems retained Gram-negative and slightly decreased Gram-positive activity. The chemical nature of the moieties substituted at C-7 and C-3 positions also influenced the antibacterial activity and spectrum. Compounds with thienyl substitution at C-7 and sulphonylmethylthiazoles or sulphonylmethylthiadiazoles at C-3 exhibited good differentials in antibacterial activity versus their unoxidized counterparts.


Chemistry of Heterocyclic Compounds | 1998

Studies on monobactams II. Synthesis and β-lactamase inhibitory activity of 4α-methyl-3-[(thien-2-yl)-methylene]-2-azetidinone-1-sulfonate

Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Chieko Kunugita; Akio Hyodo; Samarendra N. Maiti

Two monobactam derivatives, potassium 4α-methyl-(3E)-[(thien-2-yl)methylene]-2-azetidinone-1-sulfonate and its (3Z)-isomer, were prepared and evaluated for their β-lactamase inhibitory activities. These compounds were devoid of β-lactamase inhibitory activity.


Antimicrobial Agents and Chemotherapy | 1999

In Vitro and In Vivo Activities of Syn2190, a Novel β-Lactamase Inhibitor

Kouichi Nishida; Chieko Kunugita; Tatsuya Uji; Fusahiro Higashitani; Akio Hyodo; Norio Unemi; Samarendra N. Maiti; Oludotun A. Phillips; Paul Spevak; Kevin Atchison; Sameeh Salama; Harninder Atwal; Ronald G. Micetich


Journal of Antimicrobial Chemotherapy | 1990

Inhibition of β-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin

Fusahiro Higashitani; Akio Hyodo; Naofumi Ishida; Matsuhisa Inoue; Susumu Mitsuhashi


The Journal of Antibiotics | 1997

SYN-1012: A New β-Lactamase Inhibitor of Penem Skeleton

Oludotun A. Phillips; David P. Czajkowski; Paul Spevak; Maya P. Singh; Chieko Hanehara-Kunugita; Akio Hyodo; Ronald G. Micetich; Samarendra N. Maiti


The Journal of Antibiotics | 1995

Effects of Tazobactam on the Frequency of the Emergence of Resistant Strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (β-Lactamase Derepressed Mutants)

Fusahiro Higashitani; Kouichi Nishida; Akio Hyodo; Matsuhisa Inoue


Archive | 1996

Novel penam sulfones as beta-lactamase inhibitors

Fusahiro Higashitani; Akio Hyodo; Chieko Kunugita; Samarendra N. Maiti; Ronald G. Micetich; Oludotun A. Phillips; Andhe V. Narender Reddy; Eduardo L. Setti

Collaboration


Dive into the Akio Hyodo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge